Continuous‐Time Causal Inference With Marked Point Process Weights: An Example on Sodium‐Glucose Co‐Transporters 2 Inhibitor Medications and Urinary Tract Infection
Statistics in Medicine · 2025
DOI: 10.1002/sim.70102 ↗Kurz gefasst
Fachartikel in der Zeitschrift Statistics in Medicine, 2025. Verfasst von Sumeet Kalia und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Statistics, University of Manitoba, Winnipeg, Canada. Hauptthemen laut MEDLINE: Urinary Tract Infections, Sodium-Glucose Transporter 2 Inhibitors, Models, Statistical. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Natural Sciences and Engineering Research Council of Canada.
Abstract (Originalsprache)
Treatment‐confounder feedback is present in time‐to‐recurrent or longitudinal event analysis when time‐dependent confounders are themselves influenced by previous treatments. Conventional models produce misleading statistical inference of causal effects due to conditioning on these factors on the causal pathway. Marginal structural models are often applied to quantify the causal treatment effect, estimated using longitudinal weights that mimic the randomization procedure by balancing the covariate distributions across the treatment groups. The weights are usually constructed in discrete time intervals, which is appropriate if the follow‐up visits are scheduled and regular. However, in primary care, visit times can be irregular and informative, and the treatment history consists of duration and doses. This can be modeled through a continuous‐time marked point process. We constructed a continuous‐time marginal structural model to estimate the effect of cumulative exposure to Sodium‐Glucose co‐Transporters 2 Inhibitor (SGLT‐2i) medications on time‐to‐recurrent urinary tract infection (UTI). We used a cohort of type II diabetes patients with chronic kidney disease and constructed a marked point process that characterized the recurrent flare episodes of primary care visits (i.e., point process) with marks for the multinominal dose (none, low, high) of SGLT‐2i medications and recurrent episodes of UTI. We applied the stabilized and optimal treatment weights to estimate the hypothesized causal effect. Our results are concordant with earlier findings in which the recurrent episodes of UTI did not increase when patients were prescribed low dose or high dose of SGLT‐2i medications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Statistics, University of Manitoba, Winnipeg, Canada.
- Department of Family and Community Medicine, University of Toronto, Toronto, Ontario, Canada.
- Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
- School of Medicine, University of St Andrews, St Andrews, UK.
ORCID-Profile: Sumeet Kalia, Olli Saarela, Christopher Meaney
Förderung
- Natural Sciences and Engineering Research Council of Canada
Zitieren
APA
Kalia, S., Saarela, O., Chen, T., O'Neill, B., Meaney, C., Moineddin, R., Aliarzadeh, B., Sullivan, F., & Greiver, M. (2025). Continuous‐Time Causal Inference With Marked Point Process Weights: An Example on Sodium‐Glucose Co‐Transporters 2 Inhibitor Medications and Urinary Tract Infection. Statistics in Medicine. https://doi.org/10.1002/sim.70102
Vancouver
Kalia S, Saarela O, Chen T, O'Neill B, Meaney C, Moineddin R, et al. Continuous‐Time Causal Inference With Marked Point Process Weights: An Example on Sodium‐Glucose Co‐Transporters 2 Inhibitor Medications and Urinary Tract Infection. Statistics in Medicine. 2025. doi:10.1002/sim.70102
BibTeX
@article{Kalia2025,
author = {Kalia, Sumeet and Saarela, Olli and Chen, Tao and O'Neill, Braden and Meaney, Christopher and Moineddin, Rahim and Aliarzadeh, Babak and Sullivan, Frank and Greiver, Michelle},
title = {Continuous‐Time Causal Inference With Marked Point Process Weights: An Example on Sodium‐Glucose Co‐Transporters 2 Inhibitor Medications and Urinary Tract Infection},
journal = {Statistics in Medicine},
year = {2025},
doi = {10.1002/sim.70102}
}
EUVIMED